EKTAB SS

Elekta AB

Healthcare, TMT


Presented:02/28/2020
Price:SEK101.20
Cap:$4.67B
Current Price:SEK71.15
Cap:$3.28B

Presented

Date02/28/2020
PriceSEK101.20
Market Cap$4.67B
Ent Value$5.50B
P/E Ratio31.9x
Book ValueSEK21.47
Div Yield1.78%
Shares O/S382.08M
Ave Daily Vol1,974,997
Short IntN/A

Current

PriceSEK71.15
Market Cap$3.28B
Elekta AB is a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. Its products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: North and South America; Europe, Middle East and Africa; and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.

Publicly traded companies mentioned herein: Elekta AB (EKTAB SS) - Short 

Highlights

The presenter is short shares of Elekta AB (EKTAB SS) and believes that the company’s accounting figures don’t portray an accurate or realistic picture of their economic earnings. He flags their multiple lines of accounts receivables as problematic, of which the accrued income line is the most egregious.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.